BIONIK Laboratories Publicizes the Sale & Set up of a New InMotion® ARM/HAND Robotic System to Tampa Normal Hospital for its Rehabilitation Middle

BIONIK continues to develop its put in base by means of Kindred Healthcare’s community of hospitals nationwide

BOSTON, June 23, 2022–(BUSINESS WIRE)–BIONIK Laboratories Corp.. (OTCQB: BNKL) (“BIONIK” or the “Firm”), a robotics firm targeted on offering and assistive know-how options to stroke rehabilitation survivors and others with neurological and mobility challenges from hospital to house, introduced immediately that Tampa Normal Hospital (TGH) ), part of the Kindred Healthcare community, has bought and not too long ago put in an InMotion® ARM/HAND Interactive Remedy System at its Rehabilitation Hospital as a part of its missions to supply custom-made, intense rehabilitation tailor-made to the person wants of these recovering from stroke, mind harm, neurological circumstances, and extra.

InMotion® robotic techniques have been bought in additional than 15 international locations to assist stroke survivors and people with different neurological circumstances to regain arm and hand motion by coaching shoulder protraction/retraction, flexion/extension, abduction/adduction, inner/exterior rotation, elbow flexion /extension and hand grasp/launch. Within the latest affected person outcomes knowledge report from BIONIK, Utilizing IoT Knowledge to Quantify InMotion® Remedy Positive factors on Higher Extremity Motor Impairmentssufferers using its robotic gadgets measured upwards of 15-20% enchancment of their capability to maneuver extra easily, with intention, and in a managed method over a 14-day time frame.

InMotion® robotic remedy guides the affected person by means of particular duties, aiming to enhance motor management of the arm and hand by growing power, vary of movement and coordination, and helping with the availability of environment friendly, efficient, intensive sensorimotor remedy. TGH Rehabilitation Hospital is the newest facility to buy InMotion® Remedy to convey the robotic know-how to its sufferers from the Gulf Coast area of Florida.

“The InMotion machine will present TGH’s clinicians with a useful know-how that may supply every of their sufferers efficient and environment friendly remedy classes, permitting them to trace upwards of 1,000 actions per session,” mentioned Richard Russo, Jr., interim CEO and Chief Monetary Officer of BIONIK. “We’re thrilled to be working with Tampa Normal Hospital as we proceed to develop our presence with the Kindred community to succeed in extra sufferers.”

The variety of hospitals and rehabilitation facilities within the US using an InMotion® robotic machine has elevated three-fold since 2019. By means of BIONIK’s partnership with Kindred hospitals throughout the nation, who use InMotion® robotic gadgets inside their Inpatient Rehabilitation Amenities, greater than 250 sufferers use the assistive robotic gadgets every month.

andAbout BIONIK Laboratories Corp.

BIONIK Laboratories is a robotics firm targeted on offering rehabilitation and mobility options to people with neurological and mobility challenges from hospital to house. The Firm has a portfolio of merchandise targeted on higher and decrease extremity rehabilitation for stroke and different mobility-impaired sufferers, together with three merchandise in the marketplace and three merchandise in various levels of improvement. For extra data, please go to and join with us on twitter, LinkedInand Fb.

Ahead-Wanting Statements

Any statements contained on this press launch that don’t describe historic information could represent forward-looking statements. Ahead-looking statements, which contain assumptions and describe our future plans, methods, and expectations, are typically identifiable by use of the phrases “could,” “ought to,” “would,” “will,” “might,” “scheduled, ” “count on,” “anticipate,” “estimate,” “consider,” “intend,” “search,” or “challenge” or the damaging of those phrases or different variations on these phrases or comparable terminology. Ahead-looking statements could embrace, with out limitation, statements concerning (i) the plans and goals of administration for future operations, together with plans or goals referring to the design, improvement and commercialization of robotic rehabilitation merchandise, (ii) a projection of revenue ( together with revenue/loss), earnings (together with earnings/loss) per share, capital expenditures, dividends, pipeline of potential gross sales, capital construction or different monetary gadgets, (iii) the Firm’s future monetary efficiency, (iv) the market and projected marketplace for our present and deliberate merchandise and (v) the underlying assumptions or referring to any assertion described in factors (i), (ii), (iii) or (iv) above. Such forward-looking statements aren’t meant to foretell or assure precise outcomes, efficiency, occasions or circumstances, and will not be realized as a result of they’re primarily based upon the Firm’s present projections, plans, goals, beliefs, expectations, estimates and assumptions, and are topic to a lot of dangers and uncertainties and different influences, a lot of which the Firm has no management. Precise outcomes and the timing of sure occasions and circumstances could differ materially from these described by the forward-looking statements because of these dangers and uncertainties. Elements which will affect or contribute to the inaccuracy of the forward-looking statements or trigger precise outcomes to vary materially from anticipated or desired outcomes could embrace, with out limitation, the Firm’s incapacity to acquire extra financing or improve income, the lack to satisfy itemizing requirements to uplist to a nationwide inventory alternate, the numerous size of time and assets related to the event and sale of our merchandise and associated inadequate money flows and ensuing illiquidity, the continued impression on the Firm’s enterprise because of the Covid-19 pandemic, the Firm’s incapacity to develop the Firm’s enterprise, vital authorities regulation of medical gadgets and the healthcare trade, lack of product diversification, volatility within the worth of the Firm’s uncooked supplies, and the Firm’s failure to implement the Firm’s enterprise plans or methods. These and different components are recognized and described in additional element within the Firm’s filings with the SEC. The Firm doesn’t undertake to replace these forward-looking statements.

View supply model on


Ashley Willis
FischTank PR

Investor Relations:
Stephanie Prince
PCG Advisory

Leave a Comment